YOLFTbeta
Eden Research plc

Eden Research plc

EDEN · LSE · Basic Materials / Agricultural Inputs

3.55GBX+0.45 (+14.52%)

Price History

Full chart

Market Stats

Previous Close3.10
Open3.25
Day Range3.25 – 3.90
52-Week Range1.90 – 5.00
Volume7.81M
Market Cap18.64M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta1.79
50-Day Avg2.29
200-Day Avg3.08

About

Eden BioSolutions plc, together with its subsidiaries, biopesticides and plastic-free encapsulation technology for use in the global crop protection, animal health, and consumer products industries in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consumer products, such as head-lice treatment, deodorants, odour neutralizer, and fragrances, as well as food flavourings and active ingredients; and animal health products comprising companion animal, biocontrol, parasite treatments, and insect sprays. Eden BioSolutions plc was formerly known as Eden Research plc and changed its name to Eden BioSolutions plc in September 2026. The company was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.

Company Details

  • SectorBasic Materials
  • IndustryAgricultural Inputs
  • CEOMr. Sean Michael Smith
  • Employees23
  • Headquarters67C Innovation Drive, Abingdon, United Kingdom, OX14 4RQ, UK
  • Websitehttps://www.edenresearch.com

Leadership

  • Mr. Sean Michael SmithCEO & Executive Director · b. 1967
  • Mr. Alexander John AbreyCFO, Secretary & Executive Director · b. 1979

Financials

Income Statement

Currency: GBP2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312026-03-31
Total Revenue34.48K-102.56K360.79K84.00K193.00K172.00K91.00K43.59K80.22K99.86K883.31K391.96K1.88M2.77M1.83M1.37M1.23M1.83M3.19M4.30M3.88M
Growth (%)---+251.79%-76.72%+129.75%-10.88%-47.09%-52.10%+84.04%+24.47%+784.59%-55.63%+378.93%+47.79%-34.20%-25.01%-10.26%+48.72%+74.70%+34.79%-9.78%
Cost of Revenue1.29M1.44M102.56K461.25K966.39K----0098.71K28.56K1.02M1.24M963.72K1.36M1.20M1.62M1.43M2.43M2.74M
Gross Profit-1.25M-1.44M--100.46K-882.39K193.00K172.00K91.00K43.59K80.22K99.86K784.60K363.40K857.91K1.54M861.78K9.63K28.32K207.14K1.77M1.87M1.14M
Gross Margin-3636.09%---27.84%-1050.43%100.00%100.00%100.00%100.00%100.00%100.00%88.83%92.71%45.70%55.41%47.21%0.70%2.31%11.34%55.31%43.51%29.29%
Operating Expense1.08M1.02M-2.40M1.15M1.83M2.44M1.92M1.70M1.67M1.85M1.92M2.25M2.21M2.03M2.22M2.25M3.24M2.77M3.63M4.06M3.43M
Operating Income-2.34M-2.47M-3.93M-2.50M-2.03M-1.64M-2.26M-1.83M-1.66M-1.58M-1.75M-1.14M-1.89M-1.35M-497.04K-1.36M-2.24M-3.21M-2.57M-1.87M-2.19M-2.29M
Operating Margin-6778.60%--3832.97%-691.71%-2414.42%-847.67%-1315.70%-2012.09%-3803.01%-1975.65%-1748.17%-128.90%-481.27%-71.99%-17.92%-74.37%-163.86%-261.14%-140.49%-58.48%-50.81%-58.94%
EBITDA-1.01M-1.02M-2.81M-2.03M-1.42M-979.90K-1.67M-1.34M-931.45K-955.31K-1.29M-503.14K-1.21M-601.09K-88.51K-911.17K-1.87M-2.72M-1.83M-6.24M-1.59M-1.56M
EBITDA Margin-2934.54%--2742.99%-563.00%-1685.62%-507.72%-972.67%-1469.23%-2136.85%-1190.82%-1292.30%-56.96%-307.69%-32.02%-3.19%-49.91%-136.67%-221.02%-99.97%-195.64%-36.89%-40.06%
Net Income-2.30M-2.58M-4.09M-2.46M-2.10M-1.73M-3.25M-3.28M-2.32M-1.59M-2.97M-1.16M-1.83M-639.09K-334.95K-1.14M-2.27M-2.79M-2.24M-6.49M-1.91M-1.96M
Net Income Margin-6656.04%--3990.22%-682.91%-2501.38%-894.82%-1890.12%-3608.79%-5315.75%-1979.37%-2973.78%-131.00%-467.17%-34.05%-12.07%-62.71%-165.84%-227.01%-122.44%-203.45%-44.31%-50.43%
R&D165.57K198.86K410.36K114.95K12.29K35.00K25.00K--154.51K179.82K200.09K225.14K290.28K183.02K231.08K315.19K225.90K348.45K291.44K298.05K-
R&D as % of Total Revenue480.15%-400.12%31.86%14.63%18.13%14.53%--192.60%180.09%22.65%57.44%15.46%6.60%12.66%23.02%18.39%19.07%9.13%6.93%-
Interest Expense-111.33K163.07K129.81K123.44K157.00K945.00K1.25M12.32K42.62K1.25M4224841.24K5518.40K24.00K32.07K22.05K17.21K10.64K32.97K
Interest Expense % of Total Revenue--159.00%35.98%146.94%81.35%549.42%1379.12%28.27%53.13%1247.65%0.05%0.12%0.07%0.02%0.46%1.75%2.61%1.21%0.54%0.25%0.85%

Balance Sheet

Currency: GBP2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312026-03-31
Total Assets10.10M8.61M7.59M8.92M8.56M8.88M8.28M8.29M7.60M6.53M6.40M6.68M7.80M10.59M9.22M8.86M16.92M15.03M12.91M16.59M15.41M16.34M
Total Liabilities1.12M2.21M3.22M2.76M3.31M4.12M5.68M2.91M2.09M854.09K458.30K752.55K1.03M2.07M942.87K1.52M2.00M2.20M2.17M3.05M3.57M3.91M
Total Equity8.98M6.40M4.36M6.16M5.25M4.76M2.60M5.39M5.51M5.68M5.94M5.93M6.76M8.51M8.28M7.34M14.91M12.80M10.72M13.52M11.82M12.42M
Cash50.60K3.07K4.78K663.02K13.06K82.00K6.00K389.00K340.28K311.35K414.98K148.36K1.53M3.68M2.48M501.98K7.29M3.83M1.99M7.41M3.67M1.52M
Total Debt-11.70K2.66M1.83M2.27M2.05M2.95M652.00K-402.60K-----69.50K415.25K398.35K355.32K229.77K168.73K671.91K
Net Debt-50.60K8.63K2.65M1.17M2.26M1.97M2.94M263.00K-340.28K91.25K-414.98K-148.36K-1.53M-3.68M-2.48M-432.49K-6.87M-3.43M-1.64M-7.18M-3.51M-845.70K

Cash Flow

Currency: GBP2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312026-03-31
Operating Cash Flow-138.42K-705.24K-1.26M-228.59K-1.28M-432.00K-1.75M-2.63M-1.62M-1.25M-930.29K-104.86K-805.79K230.04K-701.68K-1.01M-1.02M-1.62M-683.10K-1.70M-1.01M-2.44M
Investing Cash Flow-107.24K-37.01K-4.31K-591.14K-570.83K-203.00K-105.00K-308.00K-110.84K-190.40K-466.07K-131.76K-347.87K-446.64K-510.93K-913.85K-1.90M-1.73M-1.05M-1.72M-2.48M-2.41M
Financing Cash Flow6.75K683.03K1.28M1.48M1.20M704.00K1.78M3.32M1.68M1.41M1.50M-30.00K2.54M2.36M12.97K-20.92K9.71M-90.39K-150.35K8.90M-155.53K2.64M
Capital Expenditure9.65K2.59K4.31K58.09K203.00K105.00K308.00K111.23K190.72K466.19K132.01K237.99K472.08K512.62K913.85K1.90M1.73M1.05M102.39K2.59M7.36K
Free Cash Flow-148.07K-707.83K-1.27M-228.59K-1.29M-635.00K-1.86M-2.94M-1.73M-1.44M-1.40M-236.87K-1.04M-242.04K-1.21M-1.93M-2.92M-3.34M-1.74M-1.80M-3.60M-2.45M
FCF to OCF106.97%100.37%100.34%100.00%100.63%146.99%106.00%111.72%106.86%115.31%150.11%225.89%129.53%-105.22%173.06%190.19%287.34%206.65%254.33%106.04%356.67%100.30%

Key Statistics & Ratios

Market Cap18.64M
Enterprise Value16.02M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales4.80
Price / Book1.36
EPS0.00
Book Value0.02
Revenue (TTM)3.88M
Gross Profit (TTM)1.79M
EBITDA-2.15M
Profit Margin-50.43%
Operating Margin-138.05%
Return on Equity-20.10%
Return on Assets-11.00%
Shares Outstanding803.36M
Shares Float442.77M
Beta1.79
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Mar 2, 2020650:649